Foot problems are common in people with Diabetes as a result of poor circulation or nerve damage. 15% – 25% of people with Diabetes will experience a foot ulcer at some point in their lifetime.  Ulcers occur most often on the ball of the foot or on the bottom of the big toe.  Ulcers may also appear on the sides of the foot.  Wounds on healthy people move through three major phases of healing within ten to twenty days depending on the size of the wound. As a Diabetic, if your ulcer has not progressed in the phases of healing in 4 weeks, you need to consider advanced treatment.

EpiFix Treatment for Diabetic Foot Ulcers

EpiFix Treatment for Diabetic Foot Ulcers

EpiFix Treatment for Diabetic Foot Ulcers

EpiFix is a dehydrated amnion/chorion membrane allograft (skin substitute product) that contains growth factors essential for wound healing. EpiFix when applied to an open wound will help your own cells regenerate the damaged tissue, reduce scar tissue formation, and control inflammation.


Proven Clinic Healing

EpiFix Treatments demonstrates clinical superiority in the management of diabetic foot ulcers in multiple prospective, randomized comparative studies.

EpiFix Treatment for Diabetic Foot Ulcers

If you have a wound on your foot that is hard to heal or has made no progress in healing after four weeks, it’s time to move to a more advanced treatment. Make your appointment with Next Step Foot & Ankle Clinic today to see if EpiFix is the correct treatment option for you. Call our Universal City office at 210.375.3318 or our Pleasanton location at 830.569.3338.



“Have a Hard to Heal Wound?” EpiFix Patient Brochure – English

Tiene una herida de dificil cicatrizacion? EpiFix Patient Brochure – Spanish

Independent Studies

International Wound Journal: Treatment of chronic diabetic lower extremity ulcers with advanced therapies: a prospective, randomised, controlled, multi-centre comparative study examining clinical efficacy and cost

International Wound Journal: A prospective, randomised, controlled, multi-centre comparative effectiveness study of healing using dehydrated human amnion/chorion membrane allograft, bioengineered skin substitute or standard of care for treatment of chronic lower extremity diabetic ulcers